Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Atux Iskay presents new anticancer compounds

Oct. 13, 2021

Discovery and preclinical characterization of novel TLR3 agonist, TL-532

Oct. 13, 2021

Glycogen phosphorylase identified as a therapeutic target for anaplastic thyroid cancer

Oct. 11, 2021

Filling the glass by emptying cancer cells' plates

Oct. 11, 2021

Mirati Therapeutics describes discovery and activity of GTPase KRAS inhibitor MRTX-1133

Oct. 11, 2021

New HIF-2alpha inhibitors discovered at Arcus Biosciences

Oct. 11, 2021

Yangtze River Pharmaceutical, Shanghai Haiyan Pharmaceutical patent A2A/A2B receptor antagonists

Oct. 11, 2021

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent AKT1/AKT2/AKT3 inhibitors

Oct. 11, 2021

Merck KGaA and Ryvu Therapeutics divulge new ACSS2 inhibitors

Oct. 8, 2021

Evotec presents ISR pathway modulators

Oct. 8, 2021

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...